BRUSSELS, Sept 26 (Reuters) - Edwards Lifesciences (EW.N) was raided by EU antitrust regulators at one of its facilities in an EU country a week ago, two people with direct knowledge of the matter told Reuters on Tuesday.
Edwards Lifesciences' shares dipped after the Reuters story, falling 2.5% in pre-market trade.
Edwards Lifesciences, which says it is a global leader in making medical products for structural heart disease, did not respond to repeated emailed requests for comment.
Companies found guilty of violating EU antitrust rules face fines as much as 10% of their global turnover.
According to analysts, Edwards Lifesciences competes with Abbot Laboratories (ABT.N), Medtronic (MDT.N), Zimmer Biomet (ZBH.N) and Boston Scientific Corp (BSX.N), among others.
Persons:
Edwards, Edwards Lifesciences, Zimmer Biomet, Foo Yun Chee, Kirsten Donovan, Louise Heavens
Organizations:
Reuters, European, EU, Abbot Laboratories, Boston Scientific Corp, Thomson
Locations:
BRUSSELS, EU